Loading...
BVMF
PFRM3
Market cap187mUSD
May 30, Last price  
8.72BRL
1D
0.46%
1Q
29.19%
Jan 2017
10.24%
IPO
-62.04%
Name

Profarma Distribuidora de Produtos Farmaceuticos SA

Chart & Performance

D1W1MN
No data to show
P/E
9.33
P/S
0.11
EPS
0.93
Div Yield, %
3.10%
Shrs. gr., 5y
Rev. gr., 5y
16.16%
Revenues
10.15b
+17.22%
1,519,577,0001,728,608,0002,268,874,0002,535,516,0002,578,291,0002,626,119,0003,317,048,0003,383,636,0003,470,310,0003,449,124,0003,465,143,0004,084,669,0004,100,711,0004,271,127,0004,801,292,0005,481,341,0006,413,199,0007,816,218,0008,661,744,00010,153,623,000
Net income
115m
+62.76%
16,285,000-3,552,00047,032,00031,640,00053,152,00034,382,00029,657,00040,586,00020,353,000-52,117,000-21,182,000-48,963,000-112,720,000-9,734,00011,978,00052,334,00078,192,00080,874,00070,397,000114,579,000
CFO
497m
+90.53%
-15,631,000-98,496,000-162,820,00011,027,00080,249,00044,404,00029,876,0008,934,000-90,119,00058,866,00059,265,000-107,293,000-51,826,000-55,845,000126,923,00039,344,000107,576,000126,322,000260,899,000497,088,000
Dividend
Jan 02, 20240.27004 BRL/sh
Earnings
Aug 05, 2025

Profile

Profarma Distribuidora de Produtos Farmacêuticos S.A., together with its subsidiaries, engages in the distribution and retail sale of pharmaceutical and hospital products in Brazil. The company operates through Distribution, and Retail segments. It provides branded medicines, generic drugs, and over-the-counter (OTC) medicines; personal hygiene, beauty, and cosmetic products, such as shampoos, conditioners, treatment creams and hair dyes, diapers and children's products, soaps , deodorants, oral care products, sunscreens, male products, cosmetics, makeup and skin products, and others; and hospital products, including injectable and infusion drugs for oncology, endocrinology, rheumatology, infectology, hematology, and other specialties. The company also offers vaccines for influenza, HPV, meningitis, hepatitis, chickenpox, dengue, and other diseases; special medicines intended for the treatment of rare and complex diseases; exclusive hygiene and beauty products, vitamins, and workshops products under the Nº21, GOnutri, and Bem Básico brands; and convenience products, including food products, pressure gauges, scales, and related products. In addition, it provides complementary services, such as promotional and logistical support, implementation of promotional campaigns, product recall, development of customized projects to offer laboratories solutions, and management of clinical procedures. As of December 31, 2019, the company operated eleven distribution centers located in the states of Alagoas, Bahia, Espírito Santo, Goiás, Minas Gerais, Paraíba, Paraná, Pernambuco, Rio Grande do Sul, Rio de Janeiro, and São Paulo, as well as approximately 196 stores in the states of Rio de Janeiro, Goiás, Tocantins, Mato Grosso, and Distrito Federal under the Drogarias Tamoio, Drogasmil, Farmalife, and Rede Rosário brands. The company was founded in 1961 and is headquartered in Rio de Janeiro, Brazil.
IPO date
Oct 26, 2006
Employees
Domiciled in
BR
Incorporated in
BR

Valuation

Title
BRL in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
10,153,623
17.22%
8,661,744
10.82%
7,816,218
21.88%
Cost of revenue
8,630,785
8,416,126
6,782,708
Unusual Expense (Income)
NOPBT
1,522,838
245,618
1,033,510
NOPBT Margin
15.00%
2.84%
13.22%
Operating Taxes
5,048
3,735
(6,070)
Tax Rate
0.33%
1.52%
NOPAT
1,517,790
241,883
1,039,580
Net income
114,579
62.76%
70,397
-12.95%
80,874
3.43%
Dividends
(31,229)
Dividend yield
4.34%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
359,211
298,788
221,920
Long-term debt
1,334,494
1,208,704
1,162,799
Deferred revenue
Other long-term liabilities
71,663
67,127
54,326
Net debt
1,464,153
1,268,708
1,154,819
Cash flow
Cash from operating activities
497,088
260,899
126,322
CAPEX
(28,054)
(14,012)
(10,510)
Cash from investing activities
(136,841)
(96,582)
(21,740)
Cash from financing activities
(324,438)
(153,829)
(109,844)
FCF
1,290,091
76,008
872,269
Balance
Cash
229,552
193,743
183,255
Long term investments
45,041
46,645
Excess cash
Stockholders' equity
1,201,382
1,555,392
1,683,935
Invested Capital
2,904,195
2,749,850
2,499,726
ROIC
53.69%
9.22%
42.29%
ROCE
50.99%
8.80%
40.67%
EV
Common stock shares outstanding
122,611
122,611
122,611
Price
6.24
6.30%
5.87
59.95%
3.67
-37.80%
Market cap
765,093
6.30%
719,727
59.95%
449,982
-37.80%
EV
2,511,965
2,279,112
1,924,381
EBITDA
1,692,359
394,138
1,171,731
EV/EBITDA
1.48
5.78
1.64
Interest
104,077
168,313
149,196
Interest/NOPBT
6.83%
68.53%
14.44%